Contractor
EITR BIOLOGICS, INC.
SAN DIEGO, CA
- UEI
- HX49LZLY32G5
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$33,329,6421
Awards
3
Agencies served
2
Active from Sep 22, 2023 to Jul 28, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 75A50123C00060 THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI | Department of Health and Human Services | CA | Sep 22, 2023 | $33,059,642 |
| HT942626FE033 NOVEL BISPECIFIC BROAD SPECTRUM NANOBODY | Department of Defense | CA | Mar 30, 2026 | $269,999 |
| HT942523D0011 NOVEL NANOTHERAPEUTICS FOR COMBATTING PNEUMONIC PLAGUE | Department of Defense | — | Mar 3, 2026 | — |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier HX49LZLY32G5, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.